NEWSLETTER

Clinically Speaking Newsletter:
February Issue

Issue 9: February 2025
Clinically-Speaking, Pharmacist-Led Pharmacy Benefits = Optimal Patient Health Outcomes

· EmpiRx Health’s broad network contains ~65,000 pharmacies nationwide— The same span as CVS.​

· We offer one of the only OPEN formularies in the PBM industry, meaning more coverage and less disruption for your members.

· Our contracts are 17 pages long vs. the PBM’s industry standard of 90+ pages. In short, we keep matters clear, transparent, and straightforward, which benefits all stakeholders.

In Case You Missed It:

NLMC
In February, EmpiRx Health was proud to exhibit once again at the National Labor and Management Conference. EmpiRx Health’s Shannon Strickland, PharmD, Kevin Newton, and Chris Mabie enjoyed meeting with our great partners during this prestigious national labor industry event and making new connections as well.

Thank you for another successful NLMC in 2025!

New Press Release
EmpiRx Health expressed its strong support for the House Health Subcommittee, which held a major hearing on PBM reform in February.

Our CEO, Danny Sanchez, stated: “The major PBM reform measures that have attracted bipartisan support are, in our view, table stakes in this legislative process. These measures include eliminating spread pricing, requiring full rebate pass- throughs to plan sponsors, and implementing transparency requirements.”

“For PBM reform to be truly effective, we also need to look at ending the anticompetitive practices within the PBM industry, including the vertical integration that has allowed PBMs to morph into healthcare industry conglomerates that exercise undue control over every aspect of pharmacy benefits care.”

“At EmpiRx Health, we will continue to advocate for PBM reform and look forward to working with Congress to ultimately enact legislation that will end the self-dealing, anticompetitive business practices of the traditional PBM companies,” Sanchez added.

Read the full press release here.

Image

Featured Case Study

Patient: 30-year-old female
​​​Diagnosis: Crohn’s Disease
Population Health Management Engine Identified: A new specialty therapy for the patient vs existing prescription, Humira.

• Care Management team reviewed patient’s case for clinical appropriateness, to eliminate unnecessary drug spending, and to increase the member’s access to less costly generic options.

• Clinical Pharmacist contacted prescriber to recommend a medication that optimizes treatment for this newly diagnosed condition per evidence-based clinical guidelines.

• Prescriber agreed and the patient’s condition is well-managed with the new clinical recommendation.

Annual Plan Savings: $45,913

For a Demo of Clinically and to learn more

Call or email us at: 877.361.4338 | info@empirxhealth.com
Contact Us